SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-145983
Filing Date
2024-05-23
Accepted
2024-05-23 16:16:05
Documents
14
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d840193d8k.htm   iXBRL 8-K 49385
  Complete submission text file 0001193125-24-145983.txt   220308

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mreo-20240523.xsd EX-101.SCH 3557
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20240523_def.xml EX-101.DEF 14948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20240523_lab.xml EX-101.LAB 24642
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20240523_pre.xml EX-101.PRE 15916
17 EXTRACTED XBRL INSTANCE DOCUMENT d840193d8k_htm.xml XML 6138
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 24978437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)